Determination of the Diagnostic Values of Asymmetric Dimethylarginine as an Indicator for Evaluation of the Endothelial Dysfunction in Patients with Rheumatoid Arthritis
Figure 1
Distribution of asymmetric dimethylarginine (ADMA) in serum (0.4–0.75 micromol/L).